Thrombosis and Haemostasis, Inhaltsverzeichnis Thromb Haemost 1997; 78(01): 439-444DOI: 10.1055/s-0038-1657566 Platelet activation by collagen Schattauer GmbH Stuttgart Platelet Receptors for Collagen Masaaki Moroi Department of Protein Biochemistry, Institute of Life Science, Kurume University, Kurume, Japan , S M Jung Department of Protein Biochemistry, Institute of Life Science, Kurume University, Kurume, Japan › Institutsangaben Artikel empfehlen Abstract als PDF herunterladen Artikel einzeln kaufen PDF (1169 kb) Referenzen References 1 Poole AW, Watson SP. Regulation of cytosolic calcium by collagen in single human platelets. Br J Pharmacol 1995; 115: 101-106 2 Drummond AH, MacIntyre DE. Platelet inositol lipid metabolism and calcium flux. In: Platelets in Biology and Pathology III. MacIntyre DE, and Gordon J. eds. Elsevier, Amsterdam, The Netherlands: 1987. pp 373-431 3 Haimovich B, Lipfert L, Brugge JS, Shattil SJ. Tyrosine phosphorylation and cytoskeletal reorganization in platelets are triggered by interaction of integrin receptors with their immobilized ligands. J Biol Chem 1993; 268: 15868-15877 4 Vu TKH, Hung DT, Wheaton VI, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64 1991; 1057-1068 5 Chen J, Ishii M, Wang L, Ishii K, Coughlin SR. Thrombin receptor activation. Confirmation of the intramolecular tethered liganding hypothesis and discovery of an alternative inter-molecular liganding mode. J Biol Chem 269 1994; 16041-16045 6 Jamieson GA, Urban CL, Barber AJ. Enzymatic basis for platelets:collagen adhesion as the primary step in haemostasis. Nature New Biol 1971; 234: 5-7 7 Bensusan HB, Koh TL, Henry KG, Murray BA, Culp LA. Evidence that fibronectin is the collagen receptor on platelet membranes. Proc Natl Acad Sci USA 1978; 79: 5864-5968 8 Kotite HJ, Staros JV, Cunningham LW. Interaction of specific platelet membrane proteins with collagen: evidence from chemical cross-linking. Biochemistry 1984; 23: 3099-3104 9 Saito Y, Imada T, Takagi J, Kikuchi T, Inada Y. Platelet factor XIII. The collagen receptor. J Biol Chem 261 1986; 1355-1358 10 Takagi J, Sekiya F, Kasahara K, Inada Y, Saito Y. Inhibition of platelet-collagen interaction by propolypeptide of von Willebrand factor. J Biol Chem 1989; 264: 6017-6020 11 Nieuwenhuis HK, Akkerman JWN, Houdijk WPM, Sixma JJ. Human blood platelets showing no response to collagen fail to express surface glycoprotein la. Nature 1985; 318: 470-472 12 Moroi M, Jung SM, Okuma M, Shinmyozu K. A patient with platelets deficient in glycoprotein VI that lack both collagen-induced aggregation and adhesion. J Clin Invest 1989; 84: 1440-1445 13 Gordon JL, Dingle JT. Binding of radiolabelled collagen to blood platelets. J Cell Sci 1974; 16: 157-166 14 Mazurov AV, Idel’son GL, Khachikyan MV, Domogatskii SP. Interaction of platelets with125I-labeled type III collagen. Necessity of formation of fibrillar structures. Biokhimiya 1988; 54: 1280-1289 15 Santoro SA. Identification of a 160,000 dalton platelet membrane protein that mediates the initial divalent cation-dependent adhesion of platelets to collagen. Cell 1986; 46: 913-920 16 Takada Y. Hemler ME: The primary structure of the VLA-2/ collagen receptor a2 subunit (platelet GP la): Homology to other integrins and the presence of a possible collagen-binding domain. J Cell Biol 1989; 109: 397-407 17 Argraves WS, Suzuki S, Arai H, Thompson K, Pierschbacher MD, Ruoslahti E. Amino acid sequence of the human fibronectin receptor. J Cell Biol 1987; 105: 1183-1190 18 Kamata T, Puzon W, Takada Y. Identification of putative ligand binding sites within I domain of integrin α2β1 (VLA-2, CD49b/CD29). J Biol Chem 1994; 269: 9659-9663 19 Kamata T, Takada Y. Direct binding of collagen to the I domain of integrin a2bl (VLA-2, CD49b/CD29) in a divalent cation-independent manner. J Biol Chem 1994; 269: 16006-26010 20 Takada Y, Puzon W. Identification of a regulatory region of integrin β1 subunit using activating and inhibiting antibodies. J Biol Chem 1993; 268: 17597-17601 21 Wilkins JA, Li A, Ni H, Stupack DG, Shen C. Control of β1 integrin function. Localization of stimulatory epitopes. J Biol Chem 1996; 271: 3046-3051 22 Faull RJ, Wang J, Leavesley DI, Puzon W, Russ GR, Vestweber D, Takada Y. A novel activating anti-βl integrin monoclonal antibody binds to the cysteine-rich repeats in the bl chain. J Biol Chem 1996; 271: 25099-25106 23 Keely PJ, Parise LV. The a2bl integrin is a necessary co-receptor for collagen-induced activation of Syk and the subsequent phosphorylation of phospholipase Cγ2 in platelets. J Biol Chem 1996; 271: 26668-26676 24 Sugiyama T, Okuma M, Ushikubi F, Sensaki S, Kanaji K, Uchino H. A novel platelet aggregating factor found in a patient with defective collagen-induced platelet aggregation and autoimmune thrombocytopenia. Blood 1987; 69: 1712-1720 25 Moroi M, Okuma M, Jung SM. Platelet adhesion to collagen- coated wells: analysis of this complex process and a comparison with the adhesion to matrigel-coated wells. Biochim Biophys Acta 1992; 1137: 1-9 26 Moroi M, Jung SM, Shinmyozu K, Tomiyama Y, Ordinas A, Diaz-Ricart M. Analysis of platelet adhesion to a collagen-coated surface under flow conditions: The involvement of glycoprotein VI in the platelet adhesion. Blood 1996; 88: 2081-2092 27 Ryo R, Yoshida A, Sugano W, Yasunaga M, Nakayama K, Saigo K, Adachi M, Yamaguchi N, Okuma M. Deficiency of P62, a putative collagen receptor, in platelets from a patient with defective collagen-induced platelet aggregation. Am J Hematol 1992; 39: 25-31 28 Arai M, Yamamoto N, Moroi M, Akamatsu N, Fukutake K, Tanoue K. Platelets with 10% of the normal amount of glycoprotein VI have an impaired response to collagen that results in a mild bleeding tendency. Br J Haematol 1995; 89: 124-130 29 Takahashi H, Hanano M, Moroi M, Shibata A. Platelet membrane glycoprotein VI (GPVI) is necessary for collagen-induced aggregation and adhesion and anti-GP VI antibody induces platelet aggregation: An evidence obtained from a patient with systemic lupus erythematosus. Thromb Haemostas 1995; 73: 1197 (Abst) 30 Chiang TM, Kang AH. Isolation and purification of collagen α1(1) receptor from human platelet membrane. J Biol Chem 1982; 257: 7581-7586 31 Kotite NJ, Cunningham LW. Specific adsorption of a platelet membrane glycoprotein by human insoluble collagen. J Biol Chem 1986; 261: 8342-8347 32 Chiang TM, Seyer JM, Kang AH. Collagen-platelet interaction: Separate receptor sites for types I and III collagen. Thromb Res 1993; 71: 443-456 33 Ichinohe T, Takayama H, Ezumi Y, Yanagi S, Yamamura H, Okuma M. Cyclic AMP-insensitive activation of c-Src and Syk protein-tyrosine kinases through platelet membrane glycoproteinVI. J Biol Chem 1995; 270: 28029-28036 34 Morton LF, Hargreaves PG, Farndale RW, Young RD, Barnes MJ. Integrin α2β1-independent activation of platelets by simple collagen-like peptides: collagen tertiary (triple-helical) and quaternary (polymeric) structures are sufficient alone for α2β1- independent platelet reactivity. Biochem J 1995; 306: 337-344 35 Gibbins J, Asselin J, Farndale R, Barnes M, Law CL, Watson SP. Tyrosine phosphorylation of the Fc receptor γ-chain in collagen-stimulated platelets. J Biol Chem 1996; 271: 18095-18099 36 Achison M, Joel C, Hargreaves PG, Sage SO, Barnes MJ, Farndale RW. Signals elicited from human platelets by synthetic, triple helical, collagen-like peptides. Blood Coagulation Fibrinolysis 1996; 07: 149-152 37 Tandon NN, Kralisz U, Jamieson GA. Identification of glycoprotein IV (CD36) as a primary receptor for platelet-collagen adhesion. J Biol Chem 1989; 264: 7576-7583 38 Yamamoto N, Akamatsu N, Yamazaki H, Tanoue K. Normal aggregation of GPIV (CD36)-deficient platelets from seven healthy Japanese donors. Br J Haematol 1992; 81: 86-91 39 Kehrel B, Kronenberg A, Rauterberg J, Niesing-Bresch D, Niehues U, Kardoeus J, Schwippert B, Tschope D, van de Loo J, Clemetson KJ. Platelets deficient in glycoprotein IIIb aggregate normally to collagens type I and III but not to collagen type V. Blood 1993; 82: 3364-3370 40 Diaz-Ricart M, Tandon NN, Carretero M, Ordinas A, Bastida E, Jamieson GA. Platelets lacking functional CD36 (glycoprotein IV) show reduced adhesion to collagen in flowing whole blood. Blood 1993; 82: 491-496 41 Saelman EUM, Kehrel B, Hese KM, de Groot PG, Sixma JJ, Nieuwenhuis HK. Platelet adhesion to collagen and endothelial cell matrix under flow conditions is not dependent on platelet glycoprotein IV. Blood 1994; 83: 3240-3244 42 Houdijk WPM, Sakariassen KS, Nievelstein PFEM, Sixma JJ. Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III. J Clin Invest 1985; 75: 531-540 43 Wu YP, van Breugel HHFI, Lankhof H, Wise RJ, Handin RI, de Groot PG, Sixma JJ. Platelet adhesion to multimeric and dimeric von Willebrand factor and to collagen type III preincubated with von Willebrand factor. Arterioscler Thromb Vase Biol 1996; 16: 611-620 44 Roth GJ, Titani K, Hoyer LW, Hickey MJ. Localization of binding sites within human von Willebrand factor for monomeric type III collagen. Biochemistry 1986; 25: 8357-8361 45 Alevriadou BR, Moake JL, Turner NA, Ruggeri ZM, Folie BJ, Phillips MD, Schreiber AB, Hrinda ME, Mclntire LV. Realtime analysis of shear-dependent thrombus formation and its blockade by inhibitors of von Willebrand factor binding to platelets. Blood 1993; 81: 1263-1276 46 Turner NA, Moake JL, Kamat SG, Schafer Al, Kleiman NS, Jordan R, Mclntire LV. Comparative real-time effects on platelet adhesion and aggregation under flowing conditions on in vivo aspirin, heparin, and monoclonal antibody fragment against glycoprotein IIb-IIIa. Circulation 1995; 91: 1354-1362 47 Nieuwenhuis HK, Sakariassen KS, Houdijk WPM, Nievelstein PFEM, Sixma JJ. Deficiency of platelet membrane glycoprotein la associated with a decreased platelet adhesion to subendothelium: A defect in platelet spreading. Blood 1986; 68: 692-695 48 Saelman EUM, Nieuiwenhuis HK, Hese KM, de Groot PG, Heijnen HFG, Sage EH, Williams S, McKeown L, Gralnick HR, Sixma JJ. Platelet adhesion to collagen types I through VIII under conditions of stasis and flow is mediated by GP Ia/ IIa (α2β1-integrin). Blood 1994; 83: 1244-1250
